MAP2K1 and neoplasm: SNP array identified copy number alterations in 15q22 (MAP2K1) in 21 tumours (38.9%), with 14 (66.7%) exhibiting stromal fibrosis, compared to only 7 of 33 tumours (21.2%) without gain of 15q22.